Related by context. All words. (Click for frequent words.) 61 Sepracor patents 54 patent invalidity 51 prosecution laches 51 inventorship 51 precluded summary judgment 51 nonobviousness 51 VNUS patents 51 issue preclusion 51 BSKB 50 iPCS exclusivity 50 counterclaims asserted 50 withrespect 50 arbitrable 50 Time Warp patent 50 presumptively valid 50 VirnetX patents 50 La.Civ.Code art 50 misapprehends 50 arbitrability 50 Neuftec 49 Patent Reexamination 49 ResQNet 49 ZapMedia applied 49 Reexamination Certificate 49 claim preclusion 49 biotechnological inventions 49 adequately pled 49 Summary Judgment Order 49 Allvoice 49 collaterally attack 49 EPLA 49 WARF patents 49 UKIPO 49 noninfringement 49 reviewed de novo 49 v. Teleflex Inc. 49 Markman Order 49 proximate causation 49 AVRS 49 nonappealable 49 WARF stem cell 49 overbreadth 48 intellectualproperty 48 justiciability 48 LunarEye 48 substantive unconscionability 48 prima facia 48 Hynix infringed 48 Interferences BPAI 48 preclusive effect 48 summarily affirm 48 nonstatutory 48 Interdigital 48 Linux infringes 48 ore tenus 48 appellants contend 48 JMOL 48 FRAND 48 Tenn. R. Civ 48 Wyo. Stat 47 prejudicially affect 47 GL c 47 Markman Ruling 47 ipernica 47 Air Products NanoMaterials 47 evidentiary objections 47 ipIQ 47 inapplicability 47 KSR Int'l Co. 47 requestor petitioner 47 Code Civ 47 reexamination proceeding 47 TRIPs Agreement 47 AIPLA 47 contractual indemnity 47 Visual Voicemail patents 47 La. Code Civ 47 UCB Pharma SA 47 precedential value 46 homocysteine assay 46 liberally construe 46 HTTD 46 Declaratory Judgment 46 Commil 46 WTO TRIPS Agreement 46 evidentiary rulings 46 Power Integrations patents 46 dispositions joint ventures 46 CAFC reversed 46 expressly disclaimed 46 § #-#-# [002] 46 GSM1x 46 precedential 46 legally protectable 46 dispositive motions 46 Kreutzer Limmer 46 Tax Injunction 46 contributory infringement 46 contributorily liable 46 forward lookinginformation 46 TiVo Time Warp 46 untimeliness 46 patent litigations 46 NJSA #:#-# [002] 46 DMCA subpoena 46 contractual indemnification 46 preclude summary judgment 46 interlocutory judgment 46 Collateral estoppel 46 La.Code Crim.P. art 46 non discriminatory FRAND 46 vacatur 46 Wider Networks 46 expressly disavowed 46 Dr. Siegall 46 Apple countersues Nokia 46 non infringement invalidity 46 postjudgment 46 PharmaStem 46 substantively unconscionable 46 arguable merit 46 Appellants argue 46 anticircumvention 46 reexaminations 46 Kreutzer Limmer patent 45 contemporaneous objection 45 uncharged misconduct 45 mootness 45 procompetitive 45 unconscionability 45 reexamination proceedings 45 '# patents 45 Tuschl 45 photoselective 45 Evidentiary 45 InterfeRx 45 Aarhus Convention 45 Issued Patent 45 Files Provisional 45 indemnification provisions 45 mootness doctrine 45 Cross License Agreement 45 Spreigl evidence 45 Adversary Proceeding 45 MMP Portfolio 45 x Immtech 45 ZaBeCor 45 nonprecedential 45 WTO TRIPS agreement 45 Patented Medicines Notice 45 coram nobis 45 OFDM OFDMA 45 parol evidence 45 patent reexaminations 45 posttrial motions 45 Title VII retaliation 45 constitutes patentable 45 Hexion Proposal 45 prejudicially affected 45 factually distinguishable 45 Liability Lawsuits 45 CAUTIONARY STATEMENT Statements 45 strictly construe 45 SVRX 45 additur 45 Confirms Validity 45 judicial estoppel 45 discloseable transaction 45 apply extraterritorially 45 Pumfrey J 45 Enforceability 45 called Microstructure Chromatograph 45 Mircera infringes 45 Ark. R. Civ 45 CorePharma LLC 45 ULDAGE 45 DataTreasury patents 45 Oblon Spivak 45 NQCI 45 Qualcomm GSM WCDMA 45 Triennial Review 45 Judge Luckern 44 purposeful availment 44 section #.#.# 44 Patent Portfolio 44 Uniloc patent 44 Pending Litigation 44 '# patent invalid 44 adjudicative functions 44 inter partes 44 CAFC affirmed 44 Noerr Pennington 44 Patent Litigation 44 summary judgment motions 44 TranSwitch indebtedness 44 IPONZ 44 indefiniteness 44 Rule #:#-# b 44 FCPA compliance 44 ratemaking principles 44 ripeness doctrine 44 No. RE# [001] 44 substantiality 44 TRIPS Agreement 44 liberally construing 44 quasi judicial proceeding 44 joint ventures strategic alliances 44 pari delicto 44 Les Crudele president 44 § #-#-# c [001] 44 InterDigital patents 44 Candente relies upon 44 Bionutrics 44 sua sponte dismissal 44 patentable invention 44 Appendix VII 44 indemnification clauses 44 CrR #.# 44 jurisdictional prerequisite 44 Initiates Patent Infringement 44 CJEU 44 Opening Br 44 Hatch Waxman litigation 44 e vidence 44 TechNavio Insights highlights 44 Markman Hearing 44 arbitral proceedings 44 Patents Upheld 44 SLUSA 44 Datasci 44 Intellectual Property Portfolio 44 avoid prejudicing 44 Bio3 Research 44 procedurally unconscionable 44 foreseeability 44 Pitchess motion 44 equitable indemnity 44 Phusion Laboratories 44 Reply Br 44 Interpretative Communication 44 substantive unreasonableness 44 iii Cubist 44 intercreditor agreements 44 asserted counterclaims 44 Younger abstention 44 Ariad patent 44 Friskit 44 nonjury civil 44 Wins Patent Infringement 44 equitable estoppel 44 Appellate Division affirmed 44 Reviewable 44 Reach Settlement Agreement 44 Verint Systems Inc 44 promissory fraud 44 Lord Mance 44 Patent Infringement Litigation 44 Pa.RAP 44 IEVM 44 OraTest R 44 KRS #.#-# 44 La.Code Civ.P. art 44 Patent Infringement Case 44 DISMISSED WITH PREJUDICE 44 habeas proceeding 44 § #-#.# [002] 44 Dyna Torque 43 Issue Ex Parte 43 patentable inventions 43 Lilly Evista 43 Second Amended Complaint 43 Traditionally generic drugmakers 43 interlocutory injunctions 43 antiretaliation provision 43 estoppel 43 ll.# 43 resolves patent infringement 43 Assuming arguendo 43 VIOXX Product 43 whitepaper outlines 43 equitable subrogation 43 Keith Bergelt CEO 43 Infor expressly disclaims 43 caselaw 43 fraudulent inducement 43 merely colorable 43 PAJA 43 Wis. Stat 43 nondischargeability 43 estoppel certificate 43 section #.#b 43 compulsory counterclaim 43 materiality 43 Chase Kishner 43 classwide arbitration 43 CRHI 43 Consent Judgment 43 intentional torts 43 factual determinations 43 Appellants contend 43 generic Copaxone 43 PMPRB 43 Tuschl II 43 de minimis exception 43 Princo 43 Anti Injunction 43 Intellectual Property Rights IPRs 43 Declaratory Judgment Act 43 extrinsic evidence 43 StoneTurn 43 Code § #.#-# [003] 43 Ryogen 43 waive sovereign immunity 43 Sughrue Mion 43 CORLUX CORT # 43 antenuptial agreement 43 UNCITRAL Model Law 43 AVMS Directive 43 patent infringement litigation 43 '# Patent 43 Daubert v. 43 Patent Nos. #,#,# #,#,# 43 BPAI 43 nonparties 43 inter partes reexamination 43 Non Infringement 43 anti SLAPP statute 43 FalconStor OEM 43 inter partes re 43 constitutionally delegated 43 protected biomaterial 43 exclusive sublicense 43 JNOV 43 merchant chargebacks 43 parol evidence rule 43 VIOXX Litigation 43 statements arebased 43 O2Micro logo SmartCardBus 43 Dispute Settlement Mechanism 43 VIOXX litigation 43 Plaintiffs assert 43 dispositive motion 43 infringement 43 presumptively invalid 43 nonoccurrence 43 Intellectual Property Rights TRIPS 43 GlycoGenesys 43 misapprehended 43 particularity requirement 43 LTE SAE 43 OCGA § #-#-# [007] 43 USEF governs 43 Therasense 43 ddRNAi 43 Mattel Bratz doll 43 statementsregarding 43 reasonably arguable 43 thetransaction 43 SCO copyrights 43 procedural unconscionability 43 Plaintiff asserts 43 Patent Infringement Suit 42 Prime BioResearch 42 Patent Upheld 42 Inequitable Conduct 42 sanctionable conduct 42 § #:# [001] 42 Settle Patent Litigation 42 nonfrivolous 42 u pon 42 Rule #:#-# [002] 42 IPVision 42 PLAVIX ® 42 rebuttable presumptions 42 NDCC ch 42 bsent 42 AIPPI 42 Director Jon Dudas 42 declaratory judgments 42 USVO holds similar 42 negligent misstatement 42 instruct sua sponte 42 nontestimonial 42 Grievance Procedure 42 facially valid 42 CysDisplay 42 raise triable 42 iLight patents 42 legally demandable 42 CIETAC 42 BRILINTA 42 misapplies 42 evYsio 42 % 2Fnetahtml 42 Joint Stipulation 42 Wi LAN patents 42 inequitable conduct 42 Movants 42 Tessera patents 42 Code § #A [002] 42 EP# [001] 42 Sharman License 42 interlocutory orders 42 Patentees 42 Minn. R. Civ 42 nonsuit 42 unpatentable 42 purposive interpretation 42 AEDPA statute 42 Patents Nos. 42 Defendant asserts 42 Proximate cause 42 TM MMP Portfolio 42 plead scienter 42 § #-#-# [006] 42 exculpatory clause 42 BackWeb patents 42 Settles Patent Litigation 42 p rior 42 TRIPs 42 Judgments § 42 Tercon 42 MOU establishes 42 Boykin Tahl 42 Rexahn licensees 42 postjudgment interest 42 spokesman Charles Sahner 42 Justice Pumfrey 42 hi fn inc 42 Kosan dependence 42 postconviction counsel 42 State Farm Mut 42 Synovics 42 patentable subject 42 NanoTherapies 42 subparagraph b 42 Announces Favorable Ruling 42 David Dull Broadcom 42 § #-#-# MCA 42 unenforceability 42 Scheduling Order 42 sua sponte duty 42 Accelerated Examination 42 Ipernica 42 incorporating FalconStor 42 Intervenors 42 Ravelston Entities 42 NJSA #:#-#.# [003] 42 descriptiveness 42 p ublic 42 willfully infringe 42 reasonable inferences therefrom 42 adduce evidence 42 declaratory 42 hereby DISMISSED 42 g iven 42 maritime delimitation 42 Ranbaxy Daiichi Sankyo 42 Ex Post Facto 42 Carabell v. 42 Aerocrine 42 Diomed patent 42 whitepaper explores 42 Patentability 42 unpatentability 42 Settling Parties 42 Listings Qualification Panel 42 Patent Infringement Lawsuit 42 posttrial 42 punctuation omitted 42 Entology 42 severability 42 patent reexamination 42 accused infringer 42 Delgamuukw 42 enforceability 42 Addus HomeCare Prospectus 42 Justice Cowdroy 42 protectable 42 FAA preempts 42 Implementing Regulations 42 Norwich Pharmacal 42 attendant thereto 42 Nycomed GmbH 42 qui tam litigation 42 FotoMedia 42 DG COMP 42 Mosaid patents 42 Rule #:#-# [001] 42 Saffran patent 42 ipCapital Group 42 affirmance 42 BioGlue ® 42 § #A [002] 42 LSA RS #:# [002] 42 Palmaz patent 42 Estoppel 42 purposive approach 42 subsidiarity principle 42 nonfinal 42 procedurally flawed 42 facially invalid 42 update anyforward looking 42 Matwyshyn 42 validly enacted 41 Immtech clinical trials 41 No. #.# 41 justiciable controversy 41 aEURoeThis 41 Altep Inc. 41 lenity 41 procedural reasonableness 41 habeas stripping 41 LightLab Imaging 41 conclusions de novo 41 Osiris retains 41 Intellectual Property Rights TRIPs 41 CFR #.# c 41 adjudicating disputes 41 State ex rel 41 UCBR 41 Apprendi 41 permanently enjoining 41 commercialize axon regeneration 41 Pitchess discovery 41 CSpace ® 41 Ex parte Young 41 Patent Lawsuit 41 § #-#-# [005] 41 s uch 41 TDSAT judgment 41 allowability 41 Luminex expressly disclaims 41 § #-#.# [003] 41 preliminary injunctive relief 41 clinics Physiotherapy Associates 41 Nanobody R 41 Analyte Specific Reagent 41 '# Patents 41 Determinations 41 factors APPY 41 Aplt 41 typicality 41 IRTPA 41 SOX whistleblower 41 Colo. Sess 41 mutually satisfactory definitive 41 concerning InfoSonics 41 ERISA fiduciary 41 Endotis 41 presumptively unconstitutional 41 non justiciable 41 Dyax phage display 41 judicially reviewable 41 anticompetition 41 noninfringing 41 replead 41 Amending Directive 41 factual predicates 41 Justice Kathryn Mickle 41 Mississippi Tort Claims 41 Jim Skippen Chairman 41 Judge Gajarsa 41 RE# [001] 41 Horacio Gutierrez deputy 41 counterclaimed alleging 41 unduly prejudicial 41 injurious falsehood 41 Lucent IMS 41 property Detournel 41 § #.# subd [005] 41 Obviousness 41 Memorandum Opinion 41 Dr. Sirgo 41 permanently enjoins 41 Act ERISA Breach 41 services visit http:/www.sco.com 41 Java Specification Participation 41 proprietarily developed 41 Gennum logo 41 Derivative Lawsuit 41 controverting 41 International v. Teleflex 41 injunctive action 41 Vascular Wrap TM 41 ICAP Patent 41 ex parte reexamination 41 Mutual Funds Regulations 41 Construing 41 Tuschl III 41 argument unpersuasive 41 manifest disregard 41 Secure Domain Name 41 Settling Defendants 41 CoNCERT 41 dispositive 41 Slip op 41 responsive pleadings 41 pleadings liberally 41 reexamination certificate 41 Synerx 41 applicable nonbankruptcy law 41 UNIX copyrights 41 TRIPS compliant 41 NYCHRL 41 www.vialicensing.com 41 xxxi adverse tax 41 areforward looking 41 NuRx 41 La. RS #:# [002] 41 Inc NOVL NOVL 41 prehearing 41 NJSA 2A #A 41 MiCardia 41 prosecutorial vindictiveness 41 justiciable 41 Derivative Action 41 preclusive 41 Mantrose 41 Occlutech 41 reasonable inferences drawn 41 adducing evidence 41 Vicor Technologies Announces 41 CFR § #.# [003] 41 equitable apportionment 41 summary judgment de novo 41 Kunekt Corporation 41 Copyright Royalty Judges 41 Neosil 41 Rule XIX 41 JSPA 41 TwinMOS Technologies Inc. 41 Contract Certainty 41 Thalomid R 41 Zhongyi Electronic 41 NGMN 41 VNUS Medical 41 AGORA C 41 affirmative misrepresentation 41 miRNA therapeutics 41 procedurally defective 41 DARA logo 41 drawn therefrom 41 nonsignatory 41 W OFDM 41 TechSearch 41 Speedus Corp 41 i4i patents 41 Tafas v. Doll 41 Neose subsequent 41 admissibility 41 Odyssey Thera 41 Verified Complaint 41 compensability 41 meritorious defenses 41 ex turpi causa 41 Lamfalussy process 41 ParAllele 41 Infringed 41 patent infringment 41 d efendants 41 Permanent Injunction 41 Stipulated 41 Dormant Commerce Clause 41 UniversalPHOLED 41 Infringing Products 41 intellectual property 41 Euroscreen 41 IFUE 41 successfully commercialize Iluvien 41 Rent Stabilization Code 41 Counterclaim 41 factual sufficiency 41 Plaintiffs Complaint 41 ALJ Initial Determination 41 NEC3 41 JNOV motion 41 Amended Judgment 41 Anascape patent 41 grant sublicenses 41 plainly erroneous 41 ARIPO 41 revise anyforward looking 41 infringed Broadcom 41 TecSec 41 Adaptec disclaims 41 CyberTel 40 Okla. Stat 40 nonjurisdictional 40 ZHB 40 Confrontation Clause 40 Part IIIA 40 ERISA preempts 40 Mary Lou Ambrus 40 legitimate nondiscriminatory 40 Judge Birss 40 Directive #/#/EC [006] 40 SearchHelp communications 40 Final Determination 40 Faretta motion 40 Cardium Therapeutics TM 40 KSA #-# [001] 40 DataTern 40 obviousness rejection 40 GEHC 40 Cabilly patent 40 Novosom 40 awardable 40 electro optical polymer 40 OrCrude TM process 40 futureperformance 40 Rooker Feldman doctrine 40 oligonucleotides Manoharan 40 BioSante licensees 40 Reply Brief 40 addition supplementary appendices 40 QPSX 40 www.generalpatent.com 40 materially prejudicing 40 transcatheter valve technologies 40 § #b [001] 40 sanofi aventis Novartis 40 CUTPA 40 laches 40 http:/cache.thenewsroom.com/provider graphics/watCindi Lash Pittsburgh 40 Peptelligence encompasses extensive 40 subjectto 40 § #E#.# 40 behind OUT LAW.COM 40 looking statementsare 40 SLAPP statute 40 injunction precluding 40 Settles Patent Dispute 40 competitively procured pursuant 40 Licensing Agreements 40 Dismiss Plaintiff 40 disapplied 40 biotherapeutic drugs 40 Evid. Code § 40 Sepracor licensees 40 uncontroverted facts 40 inferable 40 RAPIDGate Program contains 40 CALJIC 40 Favorable Ruling 40 explanatory memoranda 40 spokesman Tony Plohoros 40 Kolorfusion 40 Attorney Doron Weinberg 40 Cytokinetics specified 40 Justice Jagot 40 relation thereto 40 anduncertainties 40 en banc rehearing 40 overrule appellant 40 punitive incidental 40 Reinholtsen 40 suchstatements 40 OTC Bulletin Board TENF 40 Inovio AS 40 CLX Investments 40 ex mero motu 40 purposefully availed itself 40 Pandel R 40 Shigamabs 40 Speedus 40 Licence Agreements 40 Appellant asserts 40 restitutionary 40 c ounsel 40 sublicensee 40 joint tortfeasors 40 Iridex 40 Code § #-#.# 40 Leniency Notice 40 Langes + 40 SteriCorp 40 WCAB 40 elbion GmbH 40 Predictive Snooping technology 40 IRCP 40 fi ndings 40 Nazomi 40 Prometheus Laboratories 40 collateral estoppel 40 interinstitutional 40 assuming arguendo 40 Judicature Act 40 Theragenex 40 seeks declaratory 40 Norström 40 affirmative defenses 40 regardingthe 40 NeuroTherapeutics Pharma 40 Unotron holds 40 futureresults 40 Proposed Revisions 40 RNRL RIL 40 § #-#.# [004] 40 resultsof 40 spokeswoman Michele Szynal 40 construed liberally 40 O'Scannlain wrote 40 Patent Dispute 40 extracellular signaling 40 Finalisation 40 KCPA 40 constitutionally cognizable 40 KSR v. Teleflex 40 gravamen 40 Patent Licensing 40 Strand Genomics 40 FLEXnet Publisher 40 Ltd disclaims 40 patent litigation 40 Shire plc ADHD 40 SemGroup LP SemGroup 40 Lanham Act 40 TFEU 40 Arti Rai 40 Lonny Bowers 40 sub silentio 40 Michael Kwun 40 Gottfried Zuna 40 reh'g 40 tortiously interfere 40 viewpoint neutrality 40 subsidiaries visit http:/www.apricusbio.com 40 Stipulated Judgment 40 Sophoi 40 Accentra 40 Practice Direction 40 colorable 40 Ovion 40 unpatentable abstract idea 40 ClickFind 40 QbD 40 EU RoHS Directive 40 howsoever arising 40 § #-#-# b [002] 40 '# patent 40 Stephen Maebius Washington 40 normative framework 40 Crivella West 40 revealed un Earthlike 40 causal inferences 40 tortuous interference 40 Receives Favorable Ruling 40 s.# [001] 40 Rights TRIPS 40 Bilski v. Doll 40 ICSID Convention 40 apply prospectively 40 DigiBee 40 Preliminary Injunction Against 40 Innovatier 40 confidentialities 40 InterfeRx TM 40 § #A [003] 40 McDonnell Boehnen Hulbert 40 admiralty jurisdiction 40 Judicial Proceedings Article 40 ERISA preemption 40 seeks declaratory judgment 40 Nasdaq Delisting 40 limine motions 40 alleged infringer 40 Tamoxifen Citrate 40 XGen Nevis Island 40 Judge Sprizzo 40 RightTouch 40 evident partiality 40 disapply 40 Intermec RFID patents 40 ENSL 40 collaterally estopped 40 visit www.c cor.com 40 Defendant Motion 40 Ala. R. Civ 40 NACDL 40 hypertechnical 40 Bioaccelerate compounds under 40 Patent Infringement Action 40 Freeny patent 40 Michael Fricklas 40 FIPPA 40 FEHA 40 Solicitor Chrissy Adams 40 appellant asserts 40 BugOil R 40 Noerr Pennington doctrine 40 MetaCarta Incorporated 40 WIPO Performances 40 MR Civ 40 mandamus proceeding 40 geology continuity 40 High Gain Antennas 40 please contact Tzivia 40 Cavitation Technologies 40 TomoTherapy judgments 40 joint tortfeasor 40 App.R. 40 limine 40 Forwardlooking statements 40 CardXX 40 iPCS subsidiaries 40 presumptively lawful 40 Alnylam Biotherapeutics 40 overbreadth doctrine 40 Reexamination 40 thispress release 40 fraudulent joinder 40 pro se litigant 40 Defendants Motion 40 confi dential 40 EnviroMission Solar Tower 40 reflect iSIGN Media 40 mergers dispositions 40 § #-#-# b [001] 40 EPIX Pharmaceuticals 40 USAISR 40 attributing undue 40 jurisdictional defect 40 Covered Person 40 FRAND terms 40 Acceris 40 Seabed Logging 40 Files Patent Infringement 40 currentexpectations 40 s#A [001] 40 Eleventh Circuit affirmed 40 please visit www.advaxis.com 40 thisrelease 40 summary adjudication 40 CPTN 40 eprodisate KIACTA TM 40 methodologic 40 § #G#.# 39 Caliper microfluidics 39 bioequivalency 39 Appellants assert 39 derived therefrom 39 NJSA #:#-# [004] 39 IPPC Directive 39 Aegean continental shelf 39 applicability 39 SANCTURA SANCTURA XR VANTAS 39 invalid unenforceable 39 RC #.# B [002] 39 ex parte communication 39 Epson disclaims 39 Relieva 39 determinations de novo 39 Human Rights ECtHR 39 Versata Enterprises 39 Internal quotation marks 39 Interrogatory No. 39 forum non conveniens 39 NJRE 39 equitable subordination 39 Zor Pharmaceuticals 39 SASSA tender 39 Helvea analyst Olav Zilian 39 willfully infringing 39 These statementsare 39 Cabilly 39 Intellectual Property TRIPS 39 prosecutable violation 39 Petitioner contends 39 intellectual property infringement 39 Title VII disparate 39 Judge Dyk 39 i4i patent 39 CFR § #.# [006] 39 Respondent contends 39 § #-# [001] 39 developing TB4 39 repeat infringer 39 Wider Trintech Group 39 BioMarin Huxley Ltd. 39 MEMO/#/# [002] 39 § #-#-# c [002] 39 arbitral tribunal 39 Replagal TM 39 Bruesewitz v. 39 irrevocability 39 counterclaiming 39 Diamyd Medical Diamyd 39 indemnification 39 LongRun2 technologies 39 adjudicative 39 Card Activation 39 Broadened 39 Trademark Infringement Remedies 39 LightLab 39 Acticon 39 Anchen 39 inter jurisdictional 39 affidavits depositions